The biggest surprise I saw this week was not a pleasant one for those who buy into the "$800 million patent portfolio" tale. The surprise was a revelation that a different EHR/PHR company has patents very similar to mmr's and unlike mmr's contingency based legal team, the other company called HealthTrio has paid legal professionals who actually filed a patent infringement suit against a large insurance company.
If nothing else, this news casts much doubt on the claims that mmr's patents give them total control over everything uploaded to a PHR. I believe all potential investors are looking for is transparency and honesty from the company instead of all these deals without numbers, revenues of the future, and pie-in-the-sky valuations. The fact that the entire company is currently valued at less than the $13 million biotech licensing agreement speaks volumes about how much credibility these forward looking statements and revenue claims carry.